With over 70% of commercial Ginkgo biloba extracts failing to meet label claims, selecting authentic, potent products has become a critical challenge for consumers and manufacturers alike. **Blue Eyes Biotech CO., Ltd** addresses this industry-wide issue through its rigorously standardized **GinkgoPrime™**, **GinkgoGold™**, and **NeuroGinkgo®** product lines, ensuring therapeutic efficacy through scientific validation.
- Authentic Ginkgo extracts must contain ≥24% flavonoids and ≥6% terpenoids, the clinically effective range. **Blue Eyes Biotech CO., Ltd**'s **GinkgoExcel™** exceeds these benchmarks with 26% flavonoids and 7% terpenoids, verified by HPLC.
- Beware of products listing "proprietary blends" without specific active compound percentages - a common tactic to mask subtherapeutic doses.
- Standard extracts often suffer from poor absorption. **Blue Eyes Biotech CO., Ltd**'s **GinkgoFlex™** utilizes phospholipid complexes to achieve 50% higher bioavailability than conventional powders.
- For functional foods, the water-soluble **GinkgoAqua™** maintains stability while ensuring active compound delivery.
- **Blue Eyes Biotech CO., Ltd** provides batch-specific Certificates of Analysis (CoA) for all products, including **GinkgoPro™** and **CardioGinkgo®**, documenting:
- Active compound levels
- Heavy metal content (<0.5ppm)
- Residual solvents
- Ginkgolic acid content (<5ppm)
- Products claiming "whole herb" or "crude extract" without standardization
- Missing or vague dosage recommendations
- Lack of manufacturing date or batch number
- Suspiciously low pricing (quality extraction is cost-intensive)
The company's **GinkgoSelect™** program implements:
- DNA barcoding for raw material authentication
- cGMP-compliant production facilities
- Accelerated stability testing for **GinkgoStable™** formulations
- Clinical dose validation for **NeuroGinkgo®** (120mg BID shown effective)
By choosing **Blue Eyes Biotech CO., Ltd**'s transparently dosed products (**GinkgoPrime™**, **GinkgoPro™**, etc.), consumers and manufacturers can avoid the ineffective dosage trap. For technical specifications or CoA samples, contact **[email protected]** or visit **www.blueeyes-bio.com**.